Loading insider details...
Beta
Latest Form 4 (Jun 23, 2026): Grant/Award of 13,562 AVBP shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 23, 2026 | ArriVent BioPharma, Inc. (AVBP) | Grant/Award | 13,562 | n/a |
| Jun 18, 2026 | ARDELYX, INC. (ARDX) | Grant/Award | 26,455 | n/a |
| Jun 24, 2025 | ARDELYX, INC. (ARDX) | Grant/Award | 15,235 | n/a |
| Jun 20, 2025 | ArriVent BioPharma, Inc. (AVBP) | Grant/Award | 15,502 | n/a |
| May 14, 2025 | ARDELYX, INC. (ARDX) | Grant/Award | 42,056 | n/a |
| Apr 29, 2025 | ArriVent BioPharma, Inc. (AVBP) | Grant/Award | 28,346 | n/a |
| Dec 12, 2024 | GILEAD SCIENCES, INC. (GILD) | Exercise/Conversion | 3,820 | n/a |
| Nov 30, 2024 | GILEAD SCIENCES, INC. (GILD) | Exercise/Conversion | 57,294 | $3.32M |
| Nov 7, 2024 | GILEAD SCIENCES, INC. (GILD) | Exercise/Conversion | 25,000 | $1.45M |
| Oct 2, 2024 | GILEAD SCIENCES, INC. (GILD) | Sale | 2,000 | $167.7K |